Rainer Gnibl, PhD Bavarian Health Authorities

Dr. Gnibl has expertise in GMP-Inspections with a focus on analytical and medicinal chemistry. His research focuses on the synthesis of new molecules for cancer therapy (dihydrofolatereductase inhibitors) and testing with tumor-cell-banks.